NOD/SCID/γcnull mouse:: an excellent recipient mouse model for engraftment of human cells

被引:1116
|
作者
Ito, M
Hiramatsu, H
Kobayashi, K
Suzue, K
Kawahata, M
Hioki, K
Ueyama, Y
Koyanagi, Y
Sugamura, K
Tsuji, K
Heike, T
Nakahata, T
机构
[1] Kyoto Univ, Dept Pediat, Cent Inst Expt Anim, Grad Sch Med, Kawasaki, Kanagawa 2160001, Japan
[2] Gunma Univ, Dept Parasitol, Sch Med, Gunma, Japan
[3] Tokai Univ, Dept Pathol, Sch Med, Tokai, Ibaraki, Japan
[4] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan
[5] Tohoku Univ, Grad Sch Med, Dept Immunol, Sendai, Miyagi 980, Japan
[6] Univ Tokyo, Div Cellular therapy, Adv Clin Res Ctr, Inst Med Sci, Tokyo, Japan
关键词
D O I
10.1182/blood-2001-12-0207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To establish a more appropriate animal recipient for xenotransplantation, NOD SCID/gamma(c)(null) mice double homozygous for the severe combined immunodeficiency (SCID) mutation and interieukin-2Rgamma (IL-2Rgamma) allelic mutation (gamma(c)(null)) were generated by 8 backcross matings of C57BL/6J-gamma(c)(null) mice and NOD/Shi-scid mice. When human CD34(+) cells from umbilical cord blood were transplanted into this strain, the engraftment rate in the peripheral circulation, spleen, and bone marrow were significantly higher than that in NOD/Shi-scid mice treated with anti-asialo GM1 antibody or in the beta2-microglobulindeficient NOD/LtSz-scid (NOD/SCID/beta2m(null)) mice, which were as completely defective in NK cell activity as NOD/SCID/gamma(c)(null) mice. The same high engraftment rate of human mature cells was observed in ascites when peripheral blood mononuclear cells were intraperitoneally transferred. In addition to the high engraftment rate, multilineage cell differentiation was also observed. Further, even 1 x 10(2) CD34(+) cells could grow and differentiate in this strain. These results suggest that NOD/SCIO/gamma(c)(null) mice were superior animal recipients for xenotransplantation and were especially valuable for human stem cell assay. To elucidate the mechanisms involved in the superior engraftment rate in NOD/SCID/gamma(c)(null) mice, cytolkine production of spleen cells stimulated with Listeria monocytogenes antigens was compared among these 3 strains of mice. The interferon-gamma production from dendritic cells from the NOD/SCID/gamma(c)(null) mouse spleen was significantly suppressed in comparison with findings in 2 other strains of mice. It is suggested that multiple immunological dysfunctions, including cytokine production capability, in addition to functional incompetence of T, B, and NK cells, may lead to the high engraftment levels of xenograft in NOD/SCID/gamma(c)(null) mice. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3175 / 3182
页数:8
相关论文
共 50 条
  • [11] A NOD/SCID mouse model for the assessment of human platelet aggregation in vivo
    Holbrook, L.
    Moore, C.
    Sanz-Rosa, D.
    Solomon, A.
    Emerson, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (03) : 490 - 492
  • [12] Rejection of neonatal pig islet xenografts by mouse or human immune cells in NOD.SCID gamma mouse model
    Huang, Wenlong
    Rayat, Gina R.
    XENOTRANSPLANTATION, 2019, 26 (05)
  • [13] Breast cancer metastasis in a human bone NOD/SCID mouse model
    Yang, Wenyi
    Lam, Pearl
    Kitching, Richard
    Kahn, Harriette J.
    Yee, Albert
    Aubin, Jane E.
    Seth, Arun
    CANCER BIOLOGY & THERAPY, 2007, 6 (08) : 1289 - 1294
  • [14] Determination of engraftment potential of human cord blood stemprogenitor cells as a function of donor cell dosage and gestational age in the NOD/SCID mouse model
    Ural, S
    Blakemore, K
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (06) : S25 - S25
  • [15] Fate and characterization of circulating tumor cells in a NOD/SCID mouse model of human hepatocellular carcinoma
    O Scatton
    F Chiappini
    P Riou
    A Marconi
    R Saffroy
    M-P Bralet
    D Azoulay
    C Boucheix
    B Debuire
    G Uzan
    A Lemoine
    Oncogene, 2006, 25 : 4067 - 4075
  • [16] Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells
    van der Loo, JCM
    Hanenberg, H
    Cooper, RJ
    Luo, FY
    Lazaridis, EN
    Williams, DA
    BLOOD, 1998, 92 (07) : 2556 - 2570
  • [17] Homing and engraftment analysis of Stro-1+ or Stro-1- human mesenchymal stem cells in the NOD/SCID mouse model.
    Bensidhoum, M
    Chapel, A
    Germain, C
    Bouchet, S
    Mazurier, C
    Demarquay, C
    Thierry, D
    Gorin, NC
    Lopez, M
    BLOOD, 2002, 100 (11) : 527A - 527A
  • [18] Fate and characterization of circulating tumor cells in a NOD/SCID mouse model of human hepatocellular carcinoma
    Scatton, O.
    Chiappini, F.
    Riou, P.
    Marconi, A.
    Saffroy, R.
    Bralet, M. -P.
    Azoulay, D.
    Boucheix, C.
    Debuire, B.
    Uzan, G.
    Lemoine, A.
    ONCOGENE, 2006, 25 (29) : 4067 - 4075
  • [19] SCID mouse models of human stem cell engraftment
    Greiner, DL
    Hesselton, RA
    Shultz, LD
    STEM CELLS, 1998, 16 (03) : 166 - 177
  • [20] HUMAN MURINE SCID MOUSE ARTHRITIS - ENGRAFTMENT OF RA TISSUE INTO MOUSE JOINTS
    EMMRICH, F
    KAMPFER, I
    SACK, U
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1995, : 127 - 129